Stay Informed Sign up for information on attending East-West Biopharma Summit 2023

BioCentury-BayHelix East-West Summit 2022 Details

BioCentury and BayHelix invite you to Register Now to join us at the East-West BioPharma Summit at the Grand Bay Hotel San Francisco, Redwood City, CA on Nov. 14-16, 2022*.

For almost a decade, BioCentury and BayHelix and our partners have brought together a global community of C-suite executives and investors focused on biopharma innovation and cross-border collaboration. But the world has changed: Emerging biopharmas in the U.S., Europe and Asia now face the same dilemma: How do you globalize to deliver innovation to patients and achieve an ROI for investors?

  • A handful of biopharma companies will build global operations.
  • Most will achieve global economics through partnering and licensing.
  • Others will capture a share of the economics by enabling global development and financing.
  • And all will require trusted cross-border relationships for success.

Globalizing drug development is imperative for creating medicines that reach all patients, regardless of where they live. That takes investors and company leaders with global vision and strategy, in a rapidly evolving environment.

Hear from:

  • David Reese, M.D., EVP of R&D, Amgen
  • John Lepore, SVP & Head of Research, GlaxoSmithKline
  • Kiran Reddy, Senior Managing Director, Blackstone
  • Chris Carpenter, M.D., Ph.D., Executive Partner, Sofinnova Investments

And many more….

*Digital passes also available.

Download brochure

East-West Biopharma Summit Podcast: Preview

Listen to "BioCentury This Week" for a preview of the BioCentury-BayHelix East-West Biopharma Summit with special guests joining podcast host and BioCentury’s Executive Editor, Jeff Cranmer.

Organizing Committee

Steve Yang, Ph.D.
WuXi AppTec
Guo-Liang Yu, Ph.D.
former Chairman, BayHelix and
Chairman & CEO, Apollomics Inc.
Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company
Bin Li, Ph.D.
Founder, CEO & Chief Investment Officer
Lake Bleu Capital
Wendy Pan, Ph.D.
Partner, Goodwin and
Chairwoman, BayHelix
Debra Yu, M.D.
Partner & COO
Panacea Venture


Simeon George, M.D.
CEO & Managing Partner
SR One
John Lepore, M.D.
Senior Vice President and Head of Research
Nisa Leung
Managing Partner
Qiming Venture Partners
Perika Sampson
Global Head of Inclusion and Diversity
David M. Reese, M.D.
Executive Vice President, Research and Development
John Oyler
Founder, Chairman & CEO
BeiGene Ltd.


Sponsorship opportunities availableSpeak with a BioCentury representative today

Presenting Companies


2022 Presenting CompaniesJoin the BioCentury-BayHelix Presenting Company Class of 2022.


“The healthcare industry has seen a wave of innovation and development since the COVID-19 pandemic. The new era, that comes with uncertainties and macroeconomic headwinds, requires CEOs, entrepreneurs, and all to communicate effectively and embrace innovation. BioCentury and BayHelix put together a high-quality program that really captures the latest industry trends and offers a valuable opportunity to connect with thought leaders in the region. We look forward to continuing to support the BioCentury-BayHelix China Healthcare Summit, as we have in the past, and sharing our insights at the event.”

Nisa Leung
Managing Partner
Qiming Venture Partners

"The BioCentury & BayHelix China Healthcare Summit has grown from strength to strength over the last eight years. It has become the reference China event for the biopharma community, with an increasingly global audience. As McKinsey, we are proud of our contribution to the Summit as Insights Partner, with our series of reports on “Building Bridges to Innovation”. We look forward to the ninth edition of the event. Given the current context around biotech and the biopharma industry, we expect the event to be once again a great gathering of minds to crystalize trends and shape the journey together."

Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company